[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Analgesics in Japan

October 2023 | 28 pages | ID: A8742053AE0EN
Euromonitor International Ltd

US$ 990.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Sales of analgesics in Japan have seen solid growth in current value terms in 2023 backed by increased opportunities for consumers to go out, the recovery in the number of inbound tourists, and a move away from the practice of wearing face masks on a daily basis. Nonetheless, it is important to note that while overall sales of analgesics are seeing solid growth this is being driven almost entirely by the recovery of topical analgesics/anaesthetic. This is the largest category in analgesics in Ja...

Euromonitor International's Analgesics in Japan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. Forecasts to 2027 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Analgesics market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Analgesics in Japan
Euromonitor International
October 2023
List Of Contents And Tables
ANALGESICS IN JAPAN
KEY DATA FINDINGS

2023 DEVELOPMENTS

Mixed fortunes for analgesics in 2023 with topical analgesics/anaesthetic being key to growth
Salonpas benefits from rebound in demand for topical analgesics/anaesthetic, while Loxonin S continues to make waves
Players focus on adding value to their product lines
PROSPECTS AND OPPORTUNITIES
Stable outlook for analgesics with challenges and opportunities presenting themselves
New product development expected to focus on treating the causes of pain and stiffness
Players will need to address negative image issues to maintain demand
CATEGORY DATA
Table 1 Sales of Analgesics by Category: Value 2018-2023
Table 2 Sales of Analgesics by Category: % Value Growth 2018-2023
Table 3 NBO Company Shares of Analgesics: % Value 2019-2023
Table 4 LBN Brand Shares of Analgesics: % Value 2020-2023
Table 5 Forecast Sales of Analgesics by Category: Value 2023-2028
Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2023-2028
CONSUMER HEALTH IN JAPAN
EXECUTIVE SUMMARY
Consumer health in 2023: The big picture

2023 KEY TRENDS

Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2018-2023
Table 8 Life Expectancy at Birth 2018-2023
MARKET DATA
Table 9 Sales of Consumer Health by Category: Value 2018-2023
Table 10 Sales of Consumer Health by Category: % Value Growth 2018-2023
Table 11 NBO Company Shares of Consumer Health: % Value 2019-2023
Table 12 LBN Brand Shares of Consumer Health: % Value 2020-2023
Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2018-2023
Table 14 Distribution of Consumer Health by Format: % Value 2018-2023
Table 15 Distribution of Consumer Health by Format and Category: % Value 2023
Table 16 Forecast Sales of Consumer Health by Category: Value 2023-2028
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2023-2028
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources


More Publications